Please login to the form below

Not currently logged in
Email:
Password:

Pfizer collaborates with US university

Pfizer and the University of California are to work together to accelerate drug discovery and development

Pfizer is to partner with San Diego Health Sciences, part of the University of California, through the company's Centers for Therapeutic Innovation (CTI) – a network of collaborative partnerships with top-tier life science research institutions in California, Massachusetts and New York – which aims to accelerate and transform drug discovery and development.

Pfizer anticipates a potential investment of up to $50m during the next five years to support the programmes and potential milestone payments to UC San Diego Health Sciences for successful projects. The partnership includes dedicated laboratory space at Pfizer's La Jolla research and development campus for scientists from Pfizer and UC San Diego Health Sciences to work together.

“The collaborative partnerships formed through the Centers for Therapeutic Innovation between Pfizer and academic medical centers allow leading medical and clinical experts to join with Pfizer's highly-skilled scientists and advanced drug development capabilities to speed the translation of innovative science into medicines for patients," said Dr Jose Carlos Gutierrez-Ramos, senior vice-president and head of biotherapeutics research and development for Pfizer. "Our ultimate goal is to bridge the gap between scientific discovery and the delivery of promising candidates to the pipeline,” he added.

Pfizer established its first CTI in California in November 2010 through a partnership with the University of California, San Francisco. Pfizer will expand its CTI West Coast presence to southern California through a collaboration with UC San Diego Health Sciences.

Additionally, Pfizer will provide funding to support the pre-clinical and clinical development of sponsored programmes, offer CTI partners equitable intellectual property rights and grant milestone payments and royalties related to the advancement of drug candidates.

9th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics